BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-10.66%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$551M
AUM Growth
–
Cap. Flow
+$551M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.05%
Holding
130
New
130
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$21.4M |
| 2 |
CELG
Celgene Corp
CELG
|
$21.1M |
| 3 |
Medtronic
MDT
|
$20.7M |
| 4 |
Biogen
BIIB
|
$19.9M |
| 5 |
Abbott
ABT
|
$16M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93% |
| 2 | Financials | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$140B
| $21.4M | 3.89% | +233,300 | New | +$21.4M |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $21.1M | 3.82% | +210,550 | New | +$21.1M |
|
|
3
Medtronic
MDT
$119B
| $20.7M | 3.76% | +276,500 | New | +$20.7M |
|
|
4
Biogen
BIIB
$19.4B
| $19.9M | 3.62% | +76,540 | New | +$19.9M |
|
|
5
Abbott
ABT
$231B
| $16M | 2.9% | +381,500 | New | +$16M |
|
6
Amgen
AMGN
$155B
| $15.4M | 2.8% | +103,000 | New | +$15.4M |
|
7
Becton Dickinson
BDX
$55.3B
| $15.2M | 2.76% | +100,225 | New | +$15.2M |
|
8
Illumina
ILMN
$15.8B
| $14.9M | 2.7% | +91,625 | New | +$14.9M |
|
9
Stryker
SYK
$150B
| $13.4M | 2.43% | +125,000 | New | +$13.4M |
|
10
Cardinal Health
CAH
$35.5B
| $13.1M | 2.37% | +159,630 | New | +$13.1M |
|
11
UnitedHealth
UNH
$281B
| $12M | 2.18% | +93,000 | New | +$12M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $11.7M | 2.12% | +32,400 | New | +$11.7M |
|
13
Teva Pharmaceuticals
TEVA
$21.1B
| $10.5M | 1.9% | +195,290 | New | +$10.5M |
|
14
Viatris
VTRS
$12.3B
| $10.2M | 1.85% | +220,000 | New | +$10.2M |
|
15
Boston Scientific
BSX
$156B
| $9.41M | 1.71% | +500,000 | New | +$9.41M |
|
16
Zimmer Biomet
ZBH
$21B
| $9.19M | 1.67% | +86,200 | New | +$9.19M |
|
17
CVS Health
CVS
$92.8B
| $8.94M | 1.62% | +86,200 | New | +$8.94M |
|
18
Ligand Pharmaceuticals
LGND
$3.15B
| $8.76M | 1.59% | +81,830 | New | +$8.76M |
|
19
Jazz Pharmaceuticals
JAZZ
$7.75B
| $8.16M | 1.48% | +62,500 | New | +$8.16M |
|
|
CYTO
20
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $7.9M | 1.43% | +2,169,625 | New | +$7.9M |
|
21
Intuitive Surgical
ISRG
$170B
| $7.81M | 1.42% | +13,000 | New | +$7.81M |
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $6.88M | 1.25% | +49,400 | New | +$6.88M |
|
23
McKesson
MCK
$85.4B
| $6.76M | 1.23% | +43,000 | New | +$6.76M |
|
24
Supernus Pharmaceuticals
SUPN
$2.53B
| $6.73M | 1.22% | +441,000 | New | +$6.73M |
|
|
STJ
25
DELISTED
St Jude Medical
STJ
| $6.71M | 1.22% | +122,000 | New | +$6.71M |
|